不同龙蒿（Artemisia dracunculus L.）细胞型中抗糖尿病化合物的定性变化。
Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L.) cytotypes.
机构信息
Rutgers University, School of Environmental and Biological Sciences, Department of Plant Biology and Pathology, Cook Campus, New Brunswick, NJ 08901-8520, USA.
出版信息
Fitoterapia. 2011 Oct;82(7):1062-74. doi: 10.1016/j.fitote.2011.07.003. Epub 2011 Jul 21.
Abstract
Ethanolic extracts of diploid Artemisia dracunculus L. (wild tarragon) from populations in the U.S., and polyploid tarragon from a variety of sources, were screened for the anti-diabetic compounds davidigenin; sakuranetin; 2',4'-dihydroxy-4-methoxydihydrochalcone; 4,5-di-O-caffeoylquinic acid; 5-O-caffeoylquinic acid and 6-demethoxycapillarisin using LC-MS. Only decaploid plants contained all six target compounds and were the only plants that contained davidigenin and 2,4-dihydroxy-4-methoxydihydrochalcone. These results exhibit the importance of germplasm selection and provenance when studying plants for medicinal activity. Relying only on the "right species" for consistent medicinal activities may not be sufficient, as intraspecific variation may be highly significant.
摘要
采用 LC-MS 方法，对来自美国的二倍体龙蒿（野生龙蒿）和来自不同来源的多倍体龙蒿的乙醇提取物进行了抗糖尿病化合物大蓟苷元；樱花素；2',4'-二羟基-4-甲氧基二氢查耳酮；4,5-二-O-咖啡酰奎宁酸；5-O-咖啡酰奎宁酸和 6-去甲氧基毛蕊异黄酮的筛选。只有六倍体植物含有所有六种目标化合物，也是唯一含有大蓟苷元和 2,4-二羟基-4-甲氧基二氢查耳酮的植物。这些结果表明，在研究具有药用活性的植物时，种质选择和起源非常重要。仅依靠“正确的物种”来获得一致的药用活性可能还不够，因为种内变异可能非常显著。
相似文献
1
Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L.) cytotypes.不同龙蒿（Artemisia dracunculus L.）细胞型中抗糖尿病化合物的定性变化。
Fitoterapia. 2011 Oct;82(7):1062-74. doi: 10.1016/j.fitote.2011.07.003. Epub 2011 Jul 21.
2
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus.以生物测定法从龙蒿中分离醛糖还原酶抑制剂
Phytochemistry. 2006 Jul;67(14):1539-46. doi: 10.1016/j.phytochem.2006.05.015. Epub 2006 Jun 27.
3
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.龙蒿中的多酚类化合物抑制H4IIE肝癌细胞系中磷酸烯醇式丙酮酸羧激酶基因的表达和糖异生。
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1503-10. doi: 10.1152/ajpendo.00420.2007. Epub 2007 Sep 11.
4
Comparative evaluation of two different Artemisia dracunculus L. cultivars for blood sugar lowering effects in rats.两种不同龙蒿（Artemisia dracunculus L.）品种降低大鼠血糖作用的比较评价。
Phytother Res. 2012 Apr;26(4):625-9. doi: 10.1002/ptr.3605. Epub 2011 Sep 23.
5
Artemisia dracunculus L. polyphenols complexed to soy protein show enhanced bioavailability and hypoglycemic activity in C57BL/6 mice.与大豆蛋白复合的龙蒿多酚在C57BL/6小鼠中显示出增强的生物利用度和降血糖活性。
Nutrition. 2014 Jul-Aug;30(7-8 Suppl):S4-10. doi: 10.1016/j.nut.2014.03.009. Epub 2014 Mar 28.
6
The DESIGNER Approach Helps Decipher the Hypoglycemic Bioactive Principles of (Russian Tarragon).设计师方法有助于破译（俄罗斯春黄菊）的降血糖生物活性原理。
J Nat Prod. 2019 Dec 27;82(12):3321-3329. doi: 10.1021/acs.jnatprod.9b00548. Epub 2019 Dec 9.
7
Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety.龙蒿（Artemisia dracunculus L.）：对其传统用途、化学成分、药理学和安全性的批判性回顾。
J Agric Food Chem. 2011 Nov 9;59(21):11367-84. doi: 10.1021/jf202277w. Epub 2011 Oct 13.
8
Ethanol extract and isolated constituents from artemisia dracunculus inhibit esophageal squamous cell carcinoma and induce apoptotic cell death.龙蒿的乙醇提取物及分离成分可抑制食管鳞状细胞癌并诱导凋亡性细胞死亡。
Drug Res (Stuttg). 2015 Feb;65(2):101-6. doi: 10.1055/s-0034-1372647. Epub 2014 Jul 30.
9
Improved absorption and bioactivity of active compounds from an anti-diabetic extract of Artemisia dracunculus L.龙蒿抗糖尿病提取物中活性化合物的吸收及生物活性增强
Int J Pharm. 2009 Mar 31;370(1-2):87-92. doi: 10.1016/j.ijpharm.2008.11.012. Epub 2008 Nov 25.
10
Effective cytochrome P450 (CYP) inhibitors isolated from tarragon (Artemisia dracunculus).从龙蒿（狭叶青蒿）中分离出的有效细胞色素P450（CYP）抑制剂。
Biosci Biotechnol Biochem. 2012;76(5):1028-31. doi: 10.1271/bbb.120006. Epub 2012 May 7.
引用本文的文献
1
Dietary Supplementation Effects on Growth, Oxidative Status, and Immunity of Gilthead Seabream ( L.).日粮补充对金头鲷生长、氧化状态及免疫的影响
Animals (Basel). 2024 Apr 11;14(8):1161. doi: 10.3390/ani14081161.
2
Artemisia Species with High Biological Values as a Potential Source of Medicinal and Cosmetic Raw Materials.具有高生物价值的青蒿属植物作为药用和化妆品原料的潜在来源。
Molecules. 2022 Sep 29;27(19):6427. doi: 10.3390/molecules27196427.
3
and Metabolic Health: Untapped Potential of an Ancient Remedy for Modern Use.及代谢健康：古老疗法在现代应用中的未开发潜力。
Front Endocrinol (Lausanne). 2022 Feb 8;12:727061. doi: 10.3389/fendo.2021.727061. eCollection 2021.
4
(Tarragon): A Review of Its Traditional Uses, Phytochemistry and Pharmacology.（龙蒿）：其传统用途、植物化学与药理学综述
Front Pharmacol. 2021 Apr 13;12:653993. doi: 10.3389/fphar.2021.653993. eCollection 2021.
5
Inhibition of Neutrophil Functions and Antibacterial Effects of Tarragon ( L.) Infusion-Phytochemical Characterization.龙蒿（L.）浸液对中性粒细胞功能的抑制作用及抗菌效果——植物化学特征分析
Front Pharmacol. 2020 Aug 13;11:947. doi: 10.3389/fphar.2020.00947. eCollection 2020.
6
The DESIGNER Approach Helps Decipher the Hypoglycemic Bioactive Principles of (Russian Tarragon).设计师方法有助于破译（俄罗斯春黄菊）的降血糖生物活性原理。
J Nat Prod. 2019 Dec 27;82(12):3321-3329. doi: 10.1021/acs.jnatprod.9b00548. Epub 2019 Dec 9.
7
Bioactives from Artemisia dracunculus L. enhance insulin sensitivity via modulation of skeletal muscle protein phosphorylation.龙蒿中的生物活性成分通过调节骨骼肌蛋白磷酸化增强胰岛素敏感性。
Nutrition. 2014 Jul-Aug;30(7-8 Suppl):S43-51. doi: 10.1016/j.nut.2014.05.001. Epub 2014 May 13.
8
A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia.黄酮类化合物鼠李素在BV2小胶质细胞中通过烟碱受体介导的抗炎作用。
Fitoterapia. 2014 Oct;98:11-21. doi: 10.1016/j.fitote.2014.06.012. Epub 2014 Jun 24.
本文引用的文献
1
Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture.龙蒿的生物活性成分增强原代人骨骼肌培养细胞中的胰岛素信号传导。
Metabolism. 2008 Jul;57(7 Suppl 1):S58-64. doi: 10.1016/j.metabol.2008.04.003.
2
Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils.蒿属植物精油的化学成分、抗菌及抗氧化活性筛选
Phytochemistry. 2008 May;69(8):1732-8. doi: 10.1016/j.phytochem.2008.02.014. Epub 2008 Apr 15.
3
Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line.龙蒿中的多酚类化合物抑制H4IIE肝癌细胞系中磷酸烯醇式丙酮酸羧激酶基因的表达和糖异生。
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1503-10. doi: 10.1152/ajpendo.00420.2007. Epub 2007 Sep 11.
4
Antihypertensive therapies.抗高血压疗法。
Nat Rev Drug Discov. 2007 Aug;6(8):597-8. doi: 10.1038/nrd2354.
5
Antihyperglycemic activity of Tarralin, an ethanolic extract of Artemisia dracunculus L.龙蒿乙醇提取物塔拉林的降血糖活性
Phytomedicine. 2006 Sep;13(8):550-7. doi: 10.1016/j.phymed.2005.09.007. Epub 2005 Nov 2.
6
Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus.以生物测定法从龙蒿中分离醛糖还原酶抑制剂
Phytochemistry. 2006 Jul;67(14):1539-46. doi: 10.1016/j.phytochem.2006.05.015. Epub 2006 Jun 27.
7
HPLC analysis of leaf surface flavonoids for the preliminary classification of birch species.用于桦木树种初步分类的叶表面黄酮类化合物的高效液相色谱分析。
Phytochem Anal. 2006 May-Jun;17(3):197-203. doi: 10.1002/pca.906.
8
Identification and quantification of caffeoylquinic acids and flavonoids from artichoke (Cynara scolymus L.) heads, juice, and pomace by HPLC-DAD-ESI/MS(n).采用高效液相色谱-二极管阵列检测-电喷雾电离串联质谱法（HPLC-DAD-ESI/MS(n)）对洋蓟（Cynara scolymus L.）的头状花序、汁液和果渣中的咖啡酰奎宁酸和黄酮类化合物进行鉴定和定量分析。
J Agric Food Chem. 2004 Jun 30;52(13):4090-6. doi: 10.1021/jf049625x.
9
Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L. for use as a dietary supplement and in functional foods.龙蒿乙醇提取物用作膳食补充剂和功能性食品的毒理学评价。
Food Chem Toxicol. 2004 Apr;42(4):585-98. doi: 10.1016/j.fct.2003.11.002.
10
Antifungal 3-butylisocoumarins from Asteraceae-Anthemideae.
J Nat Prod. 2004 Jan;67(1):19-25. doi: 10.1021/np0301339.
Zotero 插件